Relationship between post-IVIG IgG levels and clinical outcomes in Kawasaki disease patients: new insight into the mechanism of action of IVIG

High-dose intravenous immunoglobulin is strongly associated with hemolytic anemia in patients with Kawasaki disease

(2018) Brian E. Nolan et al.   TRANSFUSION

IgG levels in Kawasaki disease and its association with clinical outcomes

(2018) Marco Antonio Yamazaki-Nakashimada et al.   CLINICAL RHEUMATOLOGY

Role of intravenous immunoglobulin in the treatment of Kawasaki disease

(2017) Mindy S. Lo et al.   International Journal of Rheumatic Diseases

Interstitial IgG antibody pharmacokinetics assessed by combined in vivo - and physiologically-based pharmacokinetic modelling approaches

(2017) Miro J. Eigenmann et al.   JOURNAL OF PHYSIOLOGY-LONDON

The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease

(2016) Yoichi Kawamura et al.   JOURNAL OF PEDIATRICS

Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease

(2016) Yu Nakagama et al.   PEDIATRICS INTERNATIONAL

Efficacy of Intravenous Immunoglobulin Combined with Prednisolone Following Resistance to Initial Intravenous Immunoglobulin Treatment of Acute Kawasaki Disease

(2013) Tohru Kobayashi et al.   JOURNAL OF PEDIATRICS

FcγR gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response

(2013) Robert Makowsky et al.   Pharmacogenetics and Genomics

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

(2012) Tohru Kobayashi et al.   LANCET

Cyclosporin A Treatment for Kawasaki Disease Refractory to Initial and Additional Intravenous Immunoglobulin

(2011) Hiroyuki Suzuki et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Importance of C-Reactive Protein Level in Predicting Non-Response to Additional Intravenous Immunoglobulin Treatment in Children with Kawasaki Disease

(2010) Satoru Iwashima et al.   CLINICAL DRUG INVESTIGATION

Pharmacokinetics of Immunoglobulin Administered via Intravenous or Subcutaneous Routes

(2008) Francisco A. Bonilla   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Infliximab Treatment of Intravenous Immunoglobulin–Resistant Kawasaki Disease

(2008) Jane C. Burns et al.   JOURNAL OF PEDIATRICS